Early Detection of Pancreatic Cancer Using Biomarker-Based Risk Score
A Biomarker-Based Risk Score that Accurately Predicts Early-Stage Pancreatic Cancer Researchers at Amsterdam University Medical Centers have developed a groundbreaking risk score utilizing established biomarkers, effectively predicting the presence of early-stage pancreatic cancer. The study’s findings, published in JAMA Network Open, indicate the potential to reduce the necessity for invasive biopsies while ensuring the accurate…